EXMceuticals (STU:9OM1) LT-Debt-to-Total-Asset : 0.02 (As of Mar. 2021)

View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. EXMceuticals's long-term debt to total assests ratio for the quarter that ended in Mar. 2021 was 0.02.

EXMceuticals's long-term debt to total assets ratio increased from Mar. 2020 (0.00) to Mar. 2021 (0.02). It may suggest that EXMceuticals is progressively becoming more dependent on debt to grow their business.

EXMceuticals LT-Debt-to-Total-Asset Historical Data

The historical data trend for EXMceuticals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals LT-Debt-to-Total-Asset Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.25

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.25	0.02	0.02	0.02

EXMceuticals LT-Debt-to-Total-Asset Calculation

EXMceuticals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2020 is calculated as

LT Debt to Total Assets (A: Jun. 2020 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2020 )	/	Total Assets (A: Jun. 2020 )
	=	0.203	/	0.82
	=

EXMceuticals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2021 is calculated as

LT Debt to Total Assets (Q: Mar. 2021 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2021 )	/	Total Assets (Q: Mar. 2021 )
	=	0.014	/	0.847
	=

EXMceuticals (STU:9OM1) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

EXMceuticals LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of EXMceuticals's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (STU:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines